KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Inventory (2016 - 2025)

Historic Inventory for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Edwards Lifesciences' Inventory rose 332.37% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 332.37%. This contributed to the annual value of $1.1 billion for FY2024, which is 2027.67% up from last year.
  • As of Q3 2025, Edwards Lifesciences' Inventory stood at $1.1 billion, which was up 332.37% from $1.1 billion recorded in Q2 2025.
  • Over the past 5 years, Edwards Lifesciences' Inventory peaked at $1.2 billion during Q1 2024, and registered a low of $726.7 million during Q4 2021.
  • In the last 5 years, Edwards Lifesciences' Inventory had a median value of $914.3 million in 2023 and averaged $934.0 million.
  • Per our database at Business Quant, Edwards Lifesciences' Inventory crashed by 942.29% in 2021 and then surged by 3623.65% in 2023.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Inventory stood at $726.7 million in 2021, then rose by 20.48% to $875.5 million in 2022, then rose by 3.2% to $903.5 million in 2023, then rose by 20.28% to $1.1 billion in 2024, then rose by 4.99% to $1.1 billion in 2025.
  • Its Inventory stands at $1.1 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.1 billion for Q1 2025.